StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > BioPub Webcast

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Feb 18, 2022 6:09pm

138 Views

Post# 34443680

RE:RE:RE:RE:BioPub Webcast

If you don't have 2k for your own health might I suggest you stop spending so much time bashing the company and go earn some extra income You only get one life make it mean something.

I know many who will pay that once it's a sinks in our city. So nice try po boy

TrippinAgain123 wrote: So Aristotle $1500 USD, so around $2000 CAD and insurance wont cover because no FDA approval. Being that Canada has free heath care and add in crazy rising inflation and gas alone this cost is going to price most people out of even having a chance to take the test in my opinion.